In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new report on regenerative medicine market is confident in meeting their needs and expectations.
The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023.
North America dominates the market due to the increasing technological advancements.
Major key players: ACELITY, OSIRIS THERAPEUTICS, INC., INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA, COOK BIOTECH INCORPORATED, ORGANOGENESIS INC.
and MERCK & CO., INC..
Increasing adoption of stem cell technology
Increasing adoption of stem cell technology, increasing prevalence of chronic diseases, emerging applications of gene therapy in regenerative medicine are some of the driving factors for Global Regenerative Medicine market. Technological advances in regenerative medicine (stem cell, tissue engineering, and nanotechnology) and high investment & funding to support development of regenerative medicine are also fuelling the market growth.
Regulatory and ethical issues
Regulatory and ethical issues pertaining stem cell, tissues engineering and regenerative medicine are acting as a restraint for Regenerative Medicine market. High cost of treatments and less awareness about the regenerative medicine among people is further restraining the market.
North America to Dominate the Market
The Regenerative Medicine market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the Regenerative Medicine market due to the increasing technological advancements and high investment & funding to support development of regenerative medicine. Asia-Pacific is also expected to propel the Regenerative Medicine market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.
Read more details of the report at: orbisresearch.com/reports/index/gl…ecasts-2018-2023
Key developments in the market
- In January, 2018: Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine
- In January, 2018: RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine
Reasons to purchase this report
- Market analysis for the Global Regenerative Medicine Market, with region-specific assessments and competition analysis on a global and regional scale.
- Analyzing various perspectives of the company with the help of Porter’s five forces analysis
- The treatment type that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
- OSIRISTHERAPEUTICS, INC.,
- INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA,
- COOK BIOTECH INCORPORATED,
- ORGANOGENESIS INC., MERCK & CO
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...